SCHEMBL3093634

SCHEMBL3093634

CCCC[Sn](CCCC)(OC(=O)c1ccc(C(=O)c2ccccc2)cc1)OC(=O)c1ccc(C(=O)c2ccccc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.48
LMNA P02545 2/20 0.46
HPGD P15428 5/20 0.45
RAB9A P51151 3/20 0.45
ELANE P08246 2/20 0.45
SRD5A2 P31213 1/20 0.42
CES2 O00748 2/20 0.41
CES1 P23141 2/20 0.41
PTPN1 P18031 1/20 0.41
ACP1 P24666 1/20 0.41
CDC25B P30305 1/20 0.41
CNR2 P34972 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
TSHR P16473 1/20 0.41
HTT P42858 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
NPC1 O15118 1/20 0.40
ABCB1 P08183 1/20 0.40
PPARA Q07869 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27954088 0.94 LMNA (0.51) LMNACES2CES1TDP1TSHR
SCHEMBL3092962 0.88 ALDH1A1 (0.48) ALDH1A1LMNAHPGDRAB9AELANE
SCHEMBL2120697 0.88 LMNA (0.49) LMNACES2CES1TDP1TSHR
SCHEMBL3093028 0.83 ELANE (0.44) ALDH1A1HPGDRAB9AELANESRD5A2
SCHEMBL5498867 0.82 CES2 (0.46) ALDH1A1LMNARAB9ACES2CES1
SCHEMBL409199 0.81 LMNA (0.51) LMNACES2CES1TDP1TSHR
SCHEMBL3098844 0.79 ELANE (0.50) ALDH1A1LMNAHPGDRAB9AELANE
SCHEMBL11132782 0.78 LMNA (0.49) LMNACES2CES1TDP1TSHR
SCHEMBL3093591 0.78 CES2 (0.51) ALDH1A1LMNACES2CES1
SCHEMBL11503163 0.76 LMNA (0.69) ALDH1A1LMNAHPGDRAB9ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2203496-B1 PHOTOLATENT CATALYSTS BASED ON ORGANOMETALLIC COMPOUNDS BASF SE (DE) 2018-04-11 EP disclosed
US-8318830-B2 Photolatent catalysts based on organometallic compounds BASF SE (DE) 2012-11-27 US disclosed
US-20100234485-A1 PHOTOLATENT CATALYSTS BASED ON ORGANOMETALLIC COMPOUNDS BASF SE (DE) 2010-09-16 US disclosed
EP-2203496-A1 PHOTOLATENT CATALYSTS BASED ON ORGANOMETALLIC COMPOUNDS BASF SE (DE) 2010-07-07 EP disclosed
WO-2009050115-A1 PHOTOLATENT CATALYSTS BASED ON ORGANOMETALLIC COMPOUNDS BASF SE (CH) 2009-04-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234485-A1 PHOTOLATENT CATALYSTS BASED ON ORGANOMETALLIC COMPOUNDS PUF60, TST, MPST ALDH1A1 1432/4885LMNA 2085/4885HPGD 1999/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.